Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug Discovery

Wednesday, August 03, 2022

Synthego the genome engineering company today announced the launch of Engineered Cell Libraries a novel offering that further enables access to CRISPR by providing arrayed CRISPRedited cells for direct use in functional screening assays The innovativ...

Krystal Biotech Receives FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial

Tuesday, August 02, 2022

Krystal Biotech Inc the leader in redosable gene therapy today announced that the United States Food and Drug Administration FDA has accepted its Investigational New Drug IND application to evaluate KB in a clinical trial for cystic fibrosis CF KB is...

Xeris’ Commercialization Partner for Ogluo®, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics

Tuesday, August 02, 2022

Xeris Biopharma Holdings Inc a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology and neurology today announced that Tetris Pharmaits commercialization partner for Ogluo in the UK EEA an...

SyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)

Monday, August 01, 2022

SyneuRx International a global biotech company focused on the development of new classes of drugs for COVID and multiple major central nervous system disorders today announced results from its phase clinical trial evaluating the efficacy and safety...

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

Friday, July 29, 2022

ANI Pharmaceuticals Inc announced the purchase of four abbreviated new drug applications ANDAs from Oakrum Pharma LLC a privately owned biopharmaceutical company We are pleased to expand our generics product portfolio with the acquisition of four lim...

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers Using AI and ML

Friday, July 29, 2022

NeuroSense Therapeutics Ltd a company developing treatments for severe neurodegenerative diseases and NeuraLight a company developing objective and sensitive biomarkers for neurological disorders today announced a collaboration to advance the science...

MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH

Wednesday, July 27, 2022

MoonLake Immunotherapeutics AG a clinicalstage biotechnology company focused on creating nextlevel therapies for inflammatory diseases today announced that it has signed a Master Development Services Agreement with Vetter Pharma International GmbH Ve...

Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with Merck

Wednesday, July 27, 2022

Sutro Biopharma Inc a clinicalstage oncology company pioneering sitespecific and novelformat antibody drug conjugates ADCs today announced that the first patient has been dosed in a Phase study of an investigational candidate resulting from the coll...

Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection, USP Simplist® Prefilled Syringe

Tuesday, July 26, 2022

Fresenius Kabi announced today the immediate availability in the US of Glycopyrrolate Injection USP in mg per mL Simplist readytoadminister prefilled syringes Fresenius Kabi Simplist Glycopyrrolate Injection USP is the most recent manufacturerprepa...

Tezspire recommended for approval in the EU by CHMP for the treatment of severe asthma

Monday, July 25, 2022

AstraZenecas Tezspire has been recommended for marketing authorisation in the European Union EU as an addon therapy in patients years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another me...